NCT07472582 A Chatbot to Reduce Chemsex and HIV-related Risk Behaviors Among Men Who Have Sex With Men
| NCT ID | NCT07472582 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-04-01 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate whether receiving chatbot-delivered stage-of-change-tailored online interventions is effective in reducing chemsex among men who have sex with men in Hong Kong. The main question it aims to answer is: Does chatbot-delivered stage-of-changed online interventions reduce chemsex among men who have sex with men Eligible participants will be randomly assigned to either the intervention or the control group. The control group will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks. On top of the interventions received by the control group, participants in the intervention group will have access to a chatbot during the 12-week intervention period. The chatbot will deliver 12 weekly episodes of interventions tailored to once's current stage-of-change related to chemsex. The chatbot will also address questions related to chemsex during the intervention period.
Eligibility Criteria
Inclusion Criteria: * Hong Kong men aged at least 18 years * Able to understand Cantonese * Had anal intercourse with at least one man within the past six months * Willingness to provide contact information for follow-up * Having access to WhatsApp Exclusion Criteria: * Self-reported a diagnosis of schizophrenia or bipolar disorder
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07472582 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07472582 currently recruiting?
Yes, NCT07472582 is actively recruiting participants. Contact the research team at wangzx@cuhk.edu.hk for enrollment information.
Where is the NCT07472582 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07472582 clinical trial?
NCT07472582 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 100 participants.